Y-Intercept »

First Tracks Biotherapeutics shares owned by Y-Intercept

Quarter-by-quarter ownership of First Tracks Biotherapeutics (TRAX) shares owned by Y-Intercept from 13F filings

Historical chart of Y-Intercept investment in First Tracks Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including First Tracks Biotherapeutics held by Y-Intercept consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in First Tracks Biotherapeutics by Y-Intercept

Quarter filed Position value Share count Share price at filing
2026-06-30 $565k 28k 20.12

More positions owned by Y-Intercept

Amazon (AMZN)
Apple (AAPL)
Boston Scientific Corporation (BSX)
Microsoft Corporation (MSFT)
Space Exploration Techn Corp Class A Com Stk (SPCX)
salesforce (CRM)
Cme (CME)
Cognizant Technology Solutio Cl A (CTSH)
Intuit (INTU)
Qualcomm (QCOM)
CBOE Holdings (CBOE)
NVIDIA Corporation (NVDA)
Accenture Plc Ireland Shs Class A (ACN)
Monolithic Power Systems (MPWR)
JPMorgan Chase & Co. (JPM)

View all positions for Y-Intercept

Top funds holding First Tracks Biotherapeutics

EcoR1 Capital
TCG Crossover Management
FMR
Affinity Asset Advisors
BlackRock
Trails Edge Capital Partners
Vanguard Capital Management
Jupiter Topco
Vestal Point Capital
Woodline Partners
Sanofi
683 Capital Management
Adage Capital Partners GP
Balyasny Asset Management
Geode Capital Management

View all funds holding First Tracks Biotherapeutics